Evidence map›Paper›PMID 29546405›Full record

ArticleCarcinogenesis2018

The molecular landscape of synchronous colorectal cancer reveals genetic heterogeneity.

Xiangfeng Wang, Hu Fang, Yong Cheng, Lin Li, Xiaohui Sun, Tao Fu, Peide Huang, Anping Zhang, Zhimin Feng, Chunxue Li and 8 more

Abstract read
In one paragraph

Article in Carcinogenesis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Xiangfeng WangDepartment of Gastrointestinal Surgery, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Hu FangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Yong ChengDepartment of Gastrointestinal Surgery, the 1st affiliated hospital of CQMU, Chongqing, China.
Lin LiBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Xiaohui SunBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Tao FuDepartment of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University, Wuhan, China.
Peide HuangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Anping ZhangDepartment of Gastrointestinal Surgery, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Zhimin FengBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Chunxue LiDepartment of Gastrointestinal Surgery, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Xuanlin HuangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Guangyan LiDepartment of Gastrointestinal Surgery, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Peina DuBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Huanming YangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Xiaodong FangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Fan LiDepartment of Gastrointestinal Surgery, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.
Qiang GaoBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Baohua LiuDepartment of Gastrointestinal Surgery, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, China.
BGI Group (China) · CNArmy Medical University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synchronous colorectal cancers (syCRCs), which present two or more lesions at diagnosis, are rare and pose a great challenge for clinical management. Although some predisposing factors associated with syCRCs have been studied with limited accession, the full repertoire of genomic events among the lesions within an individual and the causes of syCRCs remain unclear. We performed whole-exome sequencing of 40 surgical tumour samples of paired lesions from 20 patients to characterize the genetic alterations. Lesions from same patient showed distinct landscapes of somatic aberrations and shared few mutations, which suggests that they originate and develop independently, although they shared the similar genetic background. Canonical genes, such as APC, KRAS, TP53 and PIK3CA, were frequently mutated in the syCRCs, and most of them show different mutation profile compared with solitary colorectal cancer. We identified a recurrent somatic alteration (K15fs) in RPL22 in 25% of the syCRCs. Functional analysis indicated that mutated RPL22 may suppress cell apoptosis and promote the epithelial-mesenchymal transition (EMT). Potential drug targets were identified in several signalling pathways, and they present great discrepancy between lesions from the same patient. Our data show that the syCRCs within the same patient present great genetic heterogeneity, and they may be driven by distinct molecular events and develop independently. The discrepancy of potential drug targets and mutation burden in lesions from one patient provides valuable information in clinical management for patients with syCRCs.

Indexed as

ApoptosisColorectal NeoplasmsDNA Copy Number VariationsEpithelial-Mesenchymal TransitionExomeGenetic HeterogeneityGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHumansMutationSignal Transduction

Identifiers

PMID29546405
PMCPMC5932564
OpenAlexW2790717188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.